The Effects of a Novel MEK Inhibitor PD184161 on MEK-ERK Signaling and Growth in Human Liver Cancer

The MEK-ERK growth signaling pathway is important in human hepatocellular carcinoma (HCC). To evaluate the targeting of this pathway in HCC, we characterized a novel, orally-active MEK inhibitor, PD184161, using human HCC cells (HepG2, Hep3B, PLC, and SKHep) and in vivo human tumor xenografts. PD184...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Patrick J. Klein, C. Max Schmidt, Chad A. Wiesenauer, Jennifer N. Choi, Earl A. Gage, Michele T. Yip-Schneider, Eric A. Wiebke, Yufang Wang, Charles Omer, Judith S. Sebolt-Leopold
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2006-01-01
Serie:	Neoplasia: An International Journal for Oncology Research
Soggetti:	Hepatocellular carcinoma liver cancer MEK ERK PD184161
Accesso online:	http://www.sciencedirect.com/science/article/pii/S1476558606800357
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!